STRO
Sutro Biopharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$20.07
−2.29%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 7.55x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -3.22x
- Price / sales
- 7.28x
- Price / cash flow
- -2.29x
Enterprise value
- Enterprise value
- $179.2M
- EV / sales
- 3.92x
- EV / EBITDA
- -1.33x
- EV / EBIT
- -1.27x
- Market cap
- $332.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026